Toxicity in the era of immune checkpoint inhibitor therapySynat Keam, Roza Nurieva, Naimah Turner et al.|Frontiers in Immunology|2024Cited by 56
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and AtherosclerosisJun‐ichi Abe, Sivareddy Kotla, Masaki Imanishi et al.|Circulation Research|2023Cited by 39
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditisJohn R. Power, Ellen Warner, Salim S. Hayek et al.|Archives of cardiovascular diseases|2022Cited by 38
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R. Power, Anju Nohria, Charles Dolladille et al.|European Heart Journal|2025Cited by 34
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor MyocarditisJohn R. Power, Joe‐Elie Salem, Joachim Alexandre et al.|medRxiv|2021Cited by 14